Clinical Pharmacology, ASPHO Flashcards

1
Q

Gray =?

A

amount of radiation depositining 1 joule of energy into 1 kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

benefit of proton radiation?

A

Plateau dose distribution‐ deposit 90‐100% of dose at the point they
stop in tissue (Bragg peak); avoids exit dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dose of TBI? waht does it do? (2)

A
12‐15Gy in 8‐12 fractions
• Eliminate residual cancer
cells
• Make space in bone
marrow compartment
• Immune suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is teh gross tumour volume?

A

volume occpied by tumor at diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the clincial target volume?

A

• Includes gross tumor volume (GTV) and sites of suspected occult disease and involved adjacent lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the planning target volume?

A

Planning Target Volume (PTV)
• Includes CTV including surrounding geometric area accounting for variability in set up,
breathing and motion during treatment
• PTV is not the same as photons for protons
• PTV is same as CTV for brachytherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 sources of radiation for therapy?

A

photons, protons, gamma rays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3 types of IV radiotherpay?

A

Systemic Delivery (IV) Radiotherapy (Radiopharmaceuticals)
• Radio‐Iodine (RAI, 131Iodine) Gamma and Beta particles, Thyroid cancer
• 131I‐Meta‐iodobenylguanidine (131I‐MIBG): delivers beta particles via neuroendocrine
transporter to Neuroblastoma or Pheochormocytoma
• 177Lu‐ DOTO‐TATE: Beta emitting, somatostatin receptor positive GI neuroendocrine
tumors (Peptide Receptor Radiouclotide Therapy, PRRT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which familiy of drug met enzymes is responseible for 70-80% of all phase drug metabolism (activate/deactivate)? which specific enzyme is most commonly used?

A

cytochrome p450; cyp3a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which enzyme is mutated in people who have increased sensitivity to 6MP?

A

Thiopurine Methyl Transferase (TPMT), seen in 1/300

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which enzume is mutatied in gilberts disease?

A

• UDP‐glucuronosyl‐transferase 1A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 ways to overcome blood brain barrier for CNS disease?

A
  1. High‐dose chemotherapy
    • Methotrexate, cytarabine
  2. Identifying drugs which penetrate the BBB based on
    lipophilicity, molecular weight, degree of ionization, plasma
    concentration of free drug (protein binding)
    • nitrosoureas, thiotepa, topotecan
  3. Disruption of the blood‐brain barrier
    • Osmotic, radiation, vasoactive compounds,
  4. Regional Chemotherapy
    • Intra‐carotid chemotherapy (cisplatin, methotrexate)
    • Intrathecal injection (methotrexate, cytarabine)
    • Intra‐tumoral (carmustine)
    • Convection Enhanced Delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IT chemo dosing based on? exception?

A
  • Intrathecal (IT) chemotherapy dose is based on age

* IT MTX dosing based on BSA, children < 18 months had higher rate of isolated CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the goldie-coldman hypothesis? 3 points

A

• Cancer cells mutate and become resistance to therapy at a rate that
depends on the cancer’s inherent genetic instability
• Probability that a cancer contains a resistant clone is dependent on the
mutation rate and size of the tumor
• Even when tumor burden is low there is likely to be at least one drug
resistant clone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

main principle of chemo #1: give combo therapy: what does this mean? eg?

A

Concurrent administration of multiple anticancer drugs with non‐overlapping
mechanism of action and non‐overlapping toxicity profiles…Acute Lymphoblastic Leukemia: transient response rates of 60% with single agents
(MTX, MP, Prednisone, VCR, Dauno, or L‐ASP); 3‐4 drug combination induction
regimens produce durable response rate of 95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

main principel of chemo #2: adjuvant therapy: what is this?

A

Administration of chemotherapy when disease burden is
minimal but risk of recurrence is high (Goldie‐Coldman Hypothesis)
• Continuation of system therapy after local control in localized cancer
• Osteosarcoma: Improved 3 y EFS when chemotherapy administered after complete resection of
localized tumor (20% surgery alone vs 65% surgery + chemotherapy) Eilber et al J Clin Oncol 1987;5:21‐6
• Maintenance Therapy
• ALL: Methotrexate, 6‐Mercopatopurine
• RMS: vinorelbine + cyclophosphamide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Regarding adjuvant therapy, what is neoadj therapy? benefits (2)

A

Neoadjuvant Setting: Administration of systemic chemotherapy prior to
definitive local control
• Reduce tumor burden at the primary site prior to definitive local therapy
(surgery/radiation)
• Control disease not amenable to local therapy (metastases)
• Assess the sensitivity of the tumor to chemotherapy by measuring tumor response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

chemo pirnicple #3: dose intensity: what does this pertain to? eg?

A

Maximize the Dose Rate of chemotherapy
• Highest possible dose at the shortest tolerable interval
• Calculated by normalizing the dose rate (mg/m2/week) for a drug and
comparing to the dose rate of a reference drug or prior regimen.
• Examples:
• Interval Compression improved EFS in localized EWS
• Dose intensity of 4 drug induction in NBL correlates with response and survival
• Children with ALL have improved survival with standard dose vs half dose MTX and MP in
maintenance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

give 4 alkylating agnets

A
cyclophos
ifofos
cisplatin
busulfan
melphalan
temozolamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

give 2antimetabolities

A

TG

MP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

give 7 common toxicities of chemo

A
SHAM MAN
skin reactions
hepatotox
alopecia
mucositis
myelosupp
allergic rxn
n/v
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

unique tox of anthras?

A

cardiotox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

unique tox fo cyclo, ifos?

A

hemorrhagic cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

unqiue tox of alkaloids, cisplatin?

A

peirpheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
unique tox of aparaginse?
coagulopathy
26
unique tox of cisplatin?
ototox
27
unique tox of cisplatingand mtx?
nephrotox
28
unique tox of mtx?
leucoencephalopahty
29
how to attenuate myelosupp? (3)
G-CSF stem cell re-infusion individualized dosing
30
how to attenuate n/v
antiemetics
31
how to attenuate heomrrhagic cysitis?
mesna
32
how to attenuate nephrotox from cisplatin?
hyperteonic saline
33
how to attenuate cardiotox from anthras?
dexrazoxane
34
how to attenuate myelosupp/mucositis from mtx? (2)
Leucovorin | Carboxypeptidase
35
vesicant= compound that causes severe skin/eye mucosal pain and irritaiton...give 5 high chemos with high vesicant potential
think DMV= super irritating | Dauno, doxo, dactino....mitotoxin c...VBL, VCR, vinorelbine
36
how do alkylating agents work?
• Damage to the DNA template (alkyl adducts) induces apoptosis • For bifunctional alkylators (nitrogen mustards), damage results from the formation of crosslinks (inter‐strand, intra‐strand, DNA‐ protein)
37
are alkylators dependent on cell cycle?
no
38
give 5 alkylating agents
``` ifos cyclophos cisplatin carboplatin busulfan temozolamide thiotepa melphalan lomustine ```
39
give 3 alkylating agents that are pro-drugs
Cyclophosphamide Ifosfamide Dacarbazine Temozolomide
40
in what 4 ways in cisplatin worse than carbo?
periopheral neuropathy, n/v, nephrotox, ototox
41
in what 2 ways is carboplatin worse than cisplatin?
myelosupp, hypersens
42
what do audiograms show in cisplatin-related ototox?
Bilateral High Frequency (Hz > 4000) hearing loss (dB) plateau then decreases high in the x-axis
43
what compound can help with ototox in some groups?
Sodium Thiosulfate
44
how does cyclophos --> nephrotox?
- Direct tubular effect--> water retention | - hemorrhagic cystitis due to acrolein= metabolite
45
how does ifos--> GU tox?
- prox tubular damage, ricketts in younger children - decreased GFR - distal tubular damage with RTA - hemorrahgic cystitis due to acrolein= metabolite
46
how does mesna work?
chelates acrolein metabolite in the bladder
47
other than GU tox, another organ tox secondary to ifosfamide? how can you tx this?
neurotox (esp with aprepritant)...tx iwth methylene blue
48
list 4 alkylating agents
``` busulfan carmustine= BCNU cisplatin ifosfamide cyclophosphamide ```
49
late effects of alkylators? 4
- gonadal atrophy (high dose busulfan) - pulmonary fibrosis (busulfan, carmustine) - renal dysfunction(cisplatin, ifosfamide) - ototox (cisplatin) - secondayr cancers
50
mtx mech?
inhibits dihydrofolate reductase
51
antimetabolites are cell cycle specific?
yes, specific to S phase
52
folate analog?
mtx
53
purine analog?
6MP, 6TG, fludarabine, clofarabine, cladribine, melarabine=Ara-G
54
pyrimidine analogs?
Ara-C, gemcitabine, fluorouracil
55
all anti-metabolites are ___
pro-drugs
56
4 frequent toxicities of antimetabolities?
myelosupp, hepatotox, mucositis, nausea, vomiting, neurotox, rash, dermatitis, pulm tox
57
specfici tox of HD mtx?
nephrotox
58
specific tox of gemcitabine?
radiation recall
59
specific tox of 6TG?
VOD
60
specific tox of fludarabine?
immunosupp
61
specific tox of cladribine?
immunosupp
62
specific tox of ara-c?
flu-like sx
63
other than ara-c, another drug with AE= flu-like sx?
gemcitabine
64
neurotox secondary to mtx? (2) resolution?
acute encephalopathy (5-14 days later) with HD-- resolution in 1-7 days; 10-50% recur....chronic encephalopathy= permanent
65
cytarabine neutotox?
acute cerebellar syndrome...onset 3-8 days days...resolves in 1 week, but 30% have rseidual defect
66
nelarabine neutotx?
somnolence, seizures, guillain-barre-like weakness, paresthesia...gradually reversible
67
fludarabine neurotox?
progress leukoencephalopahty, can be fatal
68
what is the MAX mtx infusion duration?
42 hours...must start leucovorin within this timeframe!!
69
4 ways to maange nephrotox from HD Mtx?
- Hydration and alkalination of urine - increase leucovorin/give more often - dialysis - glucarpidase=carboxypeptidase
70
how does glucarpidase work?
cleaves mtx into DAMPA and glutamic acid
71
allopurinol's effect on 6MP? if giving both at same time do what?
allopurinol inhibits xanthine oxidase, which is responsibilie for metabolism of PO 6mp (not iV)--> 6mp becomes more bioavailable...if giving both, decresae 6MP dose by 75%!
72
give 3 drugs that interact with mtx--> decreased secretion of mtx
salicylates, pencillin, NSAIDs, ciproflox
73
topoisomerase 1 does what? 2 does wht?
--> single strand DNA breaks? ....2--> double stand DNA breaks
74
3 classes of topoisomerase inhibitors?
anthracyclines, epipodophyllotoxins, camptothecins, anthracednediones, phenoxazones
75
give 3 anthracyclines
doxo, dauno, idarubicin
76
give 2 epipodophyllotoxins
etoposide, teniposide
77
mitxantrone= what type of chemo?
anthracenedione= topoisomerase 2 inhibitor
78
dactinomycin= what type of chemo?
phenoxazone= topoisomerase 2 inhibitor
79
topotecan and irinotecan = what type of chemo?
camptothecins...= topoisomeraise ONE inhibitors
80
give 2 antitumour antibiotics
anthracyclines, dactinomycin
81
how to tx irinotecan induced diarrhea iwthin 8 hours of starting?
atropine
82
how to tx irinotecan diarrhea after 8 hours?
loperimide, octreotide
83
how to prevent irinotecan diarreha? how does this work?
cefixime; decreases glucuronidase producing bacteria in the gut
84
give 4 tubulin binding agents
vincristine, vinblastine, vinorelbine, paclitaxel, docetaxel
85
4 specific AEs of vcr?
- peripheral nueroptahy (loss of DTRs, numbness) - CN involvement (double vision) - SIADH - autonomic neuorpathy= constipation
86
3 drugs that reduce clearance of vinca alkaloids?
fluconazole, cipro, grapefruit juice
87
3 drugs taht increase clearance of vinca alkaloids?
st johns wort, phenobarb, rifampin
88
5 AEs of steroids?
AVN, htn, diabetes, immunouppression, growth failiure, centripedal obesity
89
tox assoicated with bleomycin
interstitial pneumonitis, alopecia, reynaud, hyperpigemntation of skin and nails
90
goals of phase 1 trial?
establish safe dose, establish tox profile, establish pharmacology
91
population used in phase 1 trials?
relapsed cancer, <25 pts
92
phase 2 trial goal?
determine response to a certain drug
93
populaiton for phase 2 trial?
relapased cancer pts
94
goal of phase 3 trail?
efficacy (benefit) of drug, with endpoint being survival
95
population in phase 3 trial?
untreated cancer pts
96
3 AEs of Aresnic trioxide?
prolonged QTc, leukocytosis, APL differentation syndrome
97
3 AEs of ATRA?
differentation syndrome, venous thrombosis, pseudotumour cerebri
98
3 AEs of imatinib?
increased transaminases, n/v, fatigue
99
2AEs of crizotinib?
hepatotox, AKI
100
NTRK fusion (NTRK-ETV6) seen in which tumours?
congential mesoblastic neprhoma, infantile fibrosarcoma
101
give an NTRK inhibitor
larotrectinib
102
give an inhibitor of dna methylation
azacitidine
103
give an immune hceckpoint inhibitor and an AE of it
nivolumab, pleural effusion
104
give 3 MABs used to treat cancer, the cancer they treat, mech, and AE
- avastin=bevacizumab; LGG; blocks angiogenesiss via VEGF inhibition; hypertesnion - rituximab; PTLD and b-cell lymphoma; inhibits CD20-> depletes normal b-cells--> hypogammaglobulinemia - dintuximab, NBL, anti-GD2--> antibody dependent cell mediated toxicity; neuropathic pain
105
AE of gemtuzumab?
infusion-related reaction, myelosupp
106
AE of inotuzumab?
infusion-related reaction, myelosupp, VOD
107
AE of brentuximab?
neutropenia, neuropathy